Join
Live feed
·
INSIDERFilingvia Quantisnow
Molecular Templates Inc. logo

SEC Form 4: V N Target Biotech bought $1,887,100 worth of Common Stock (200,000 units at $9.44), increasing direct ownership by 2% to 8,316,105 units

ByQuantisnow·Wall Street's wire, on your screen.
MTEM· Molecular Templates Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MTEM (Molecular Templates Inc.) and more on Quantisnow.